Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,864 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib.
Park KS, Oh B, Lee MH, Nam KY, Jin HR, Yang H, Choi J, Kim SW, Lee DH. Park KS, et al. Cancer Lett. 2016 Mar 1;372(1):75-81. doi: 10.1016/j.canlet.2015.12.015. Epub 2015 Dec 23. Cancer Lett. 2016. PMID: 26723875
The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer.
Park KS, Yang H, Choi J, Seo S, Kim D, Lee CH, Jeon H, Kim SW, Lee DH. Park KS, et al. Cancer Lett. 2017 Oct 10;406:47-53. doi: 10.1016/j.canlet.2017.07.028. Epub 2017 Aug 7. Cancer Lett. 2017. PMID: 28797845
Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.
Thomas A, Lee JH, Abdullaev Z, Park KS, Pineda M, Saidkhodjaeva L, Miettinen M, Wang Y, Pack SD, Giaccone G. Thomas A, et al. J Thorac Oncol. 2014 Apr;9(4):567-71. doi: 10.1097/JTO.0000000000000089. J Thorac Oncol. 2014. PMID: 24736083 Free PMC article.
Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.
Choi CM, Jang SJ, Park SY, Choi YB, Jeong JH, Kim DS, Kim HK, Park KS, Nam BH, Kim HR; Korean Thoracic Oncology Research Group (KTORG), Kim SY, Hong KM. Choi CM, et al. Mol Cancer. 2011 Sep 24;10:119. doi: 10.1186/1476-4598-10-119. Mol Cancer. 2011. PMID: 21943122 Free PMC article.
I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway.
Kim DS, Han BG, Park KS, Lee BI, Kim SY, Bae CD. Kim DS, et al. Biochem Biophys Res Commun. 2010 Aug 20;399(2):300-6. doi: 10.1016/j.bbrc.2010.07.078. Epub 2010 Jul 24. Biochem Biophys Res Commun. 2010. PMID: 20659425
Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.
Park KS, Kim HK, Lee JH, Choi YB, Park SY, Yang SH, Kim SY, Hong KM. Park KS, et al. J Cancer Res Clin Oncol. 2010 Apr;136(4):493-502. doi: 10.1007/s00432-009-0681-6. Epub 2009 Sep 18. J Cancer Res Clin Oncol. 2010. PMID: 19763620
2,864 results
Jump to page
Feedback